Search

Your search keyword '"LU Wenxia"' showing total 98 results

Search Constraints

Start Over You searched for: Author "LU Wenxia" Remove constraint Author: "LU Wenxia" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
98 results on '"LU Wenxia"'

Search Results

1. Evaluation of Droplet Size and Drift Distribution of Herbicide Sprayed by Plant Protection Unmanned Aerial Vehicle in Winter Wheat Field

4. Discovery of a novel hybrid coumarin-hydroxamate conjugate targeting the HDAC1-Sp1-FOSL2 signaling axis for breast cancer therapy.

5. Online soft measurement method for chemical oxygen demand based on CNN-BiLSTM-Attention algorithm.

10. Enhanced Feature Extraction Network Based on Acoustic Signal Feature Learning for Bearing Fault Diagnosis.

11. Modeling Method for Aerobic Zone of A 2 O Based on KPCA-PSO-SCN.

13. An insight into the origin of elemental chromium in the lacquer of Qin terracotta warriors

14. The Challenges Ahead for Exosomes Treatment for Diabetes Mellitus [Letter]

15. Lesson Learned from MRI Evaluation of Mullerian Duct Anomalies [Letter]

18. Research progress of brain magnetic resonance imaging related to suicide in bipolar disorder patients

22. Clinical value of urinary retinol‑binding protein in ascites due to cirrhosis

23. Hemodynamic effects of renin-angiotensin-aldosterone inhibitor and β-blocker combination therapy vs. β-blocker monotherapy for portal hypertension in cirrhosis: A meta-analysis

24. Combination therapy of fenofibrate and ursodeoxycholic acid in patients with primary biliary cirrhosis who respond incompletely to UDCA monotherapy: a meta-analysis

25. Combination therapy of ursodeoxycholic acid and budesonide for PBC–AIH overlap syndrome: a meta-analysis

27. Effects of Omega-3 Fatty Acid in Nonalcoholic Fatty Liver Disease: A Meta-Analysis

28. Combination therapy of fenofibrate and ursodeoxycholic acid in patients with primary biliary cirrhosis who respond incompletely to UDCA monotherapy: a meta-analysis

29. Systematic review and meta-analysis: bezafibrate in patients with primary biliary cirrhosis [Erratum]

30. Combination therapy of ursodeoxycholic acid and budesonide for PBC–AIH overlap syndrome: a meta-analysis

31. Systematic review and meta-analysis: bezafibrate in patients with primary biliary cirrhosis

32. Inhibitive effects of 15-deoxy-Δ12,14-prostaglandin J2 on hepatoma-cell proliferation through reactive oxygen species-mediated apoptosis

33. Inhibitive effects of 15-deoxy-Δ12,14-prostaglandin J2 on hepatoma-cell proliferation through reactive oxygen species-mediated apoptosis

34. Systematic review and meta-analysis: bezafibrate in patients with primary biliary cirrhosis [Erratum]

35. Astaxanthin Inhibits Proliferation and Induces Apoptosis of Human Hepatocellular Carcinoma Cells via Inhibition of Nf-Κb P65 and Wnt/Β-Catenin in Vitro

36. Astaxanthin Pretreatment Attenuates Hepatic Ischemia Reperfusion-Induced Apoptosis and Autophagy via the ROS/MAPK Pathway in Mice

37. Combination therapy of fenofibrate and ursodeoxycholic acid in patients with primary biliary cirrhosis who respond incompletely to UDCA monotherapy: a meta-analysis

38. By reducing hexokinase 2, resveratrol induces apoptosis in HCC cells addicted to aerobic glycolysis and inhibits tumor growth in mice

39. Protective Effects of Astaxanthin on ConA-Induced Autoimmune Hepatitis by the JNK/p-JNK Pathway-Mediated Inhibition of Autophagy and Apoptosis

41. The Protective Effect of Resveratrol on Concanavalin-A-Induced Acute Hepatic Injury in Mice

42. Combination therapy of ursodeoxycholic acid and budesonide for PBC–AIH overlap syndrome: a meta-analysis

45. Design and optimization of novel Tetrahydro-β-carboline-based HDAC inhibitors with potent activities against tumor cell growth and metastasis.

47. Inhibitive effects of 15-deoxy-Δ(12),(14)-prostaglandin J2 on hepatoma-cell proliferation through reactive oxygen species-mediated apoptosis.

48. Systematic review and meta-analysis: bezafibrate in patients with primary biliary cirrhosis.

49. Combination therapy of fenofibrate and ursodeoxycholic acid in patients with primary biliary cirrhosis who respond incompletely to UDCA monotherapy: a meta-analysis.

50. Combination therapy of ursodeoxycholic acid and budesonide for PBC-AIH overlap syndrome: a meta-analysis.

Catalog

Books, media, physical & digital resources